Study into conolidine has resulted in discovery of an opioid receptor in the human body identified as ACKR3/CXCR7. ACKR3 is apparently by far the most desired target for conolidine, which also disregards the opposite four classical opioid receptors(three). We have been independently owned as well as views expressed here https://gregoryuaccc.xzblogs.com/78156113/what-does-alternative-natural-pain-relief-to-replace-traditional-painkillers-mean